Lindsay Borgeson is a corporate healthcare partner in the New York office of Kirkland & Ellis LLP, focusing on healthcare regulatory and transactional matters for health care entities and related companies (e.g., investors, lenders). Lindsay counsels clients on a broad range of healthcare related matters, including state laws related to licensure and the corporate practice of medicine, federal healthcare fraud and abuse laws such as the Anti-Kickback Statute and the Stark Law, and other related regulatory matters. Lindsay also routinely counsels clients on federal privacy matters, including compliance with HIPAA's Privacy, Security and Breach Notification Rules.
Lindsay is frequently called upon to advise on large corporate transactions involving healthcare regulatory matters. Such transactions frequently involve strategic acquirers, including private equity funds, and public companies, and cover a broad spectrum of healthcare services (e.g., behavioral health providers, pharmacies, home healthcare agencies, telemedicine, physicians, dentists, healthcare IT, and other healthcare providers and entities). Lindsay regularly advises on complex liability management exercises for healthcare entities, including Chapter 11 bankruptcy filings.
Lindsay was recognized by Law360 as a “Rising Star” in 2023 for her work in Healthcare.
Co-author, "Healthcare Staffing Agencies See Tightened Rules in Covid Era," Bloomberg Law, June 6, 2023
Co-author, "2023 Healthcare Private Equity Outlook and Considerations," Kirkland Alert, March 8, 2023
Panelist, "Healthcare M&A and Assessing Material Regulatory Risks: Reimbursement, Fraud and Abuse, Licensure, Privacy," Strafford, Webinar, June 15, 2022
Panelist, “Healthcare Law,” Cardozo Healthcare Law Society, April 15, 2021
Admissions & Qualifications
- New York
- New Jersey
- Seton Hall University School of LawJ.D.magna cum laude2014
Order of the Coif
Seton Hall Law Review
- Wellesley CollegeB.A., Political Science & Women’s Studies2009